1. Market Research
  2. > Cancer Industry

Prostate Cancer Industry, February 2017 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Cancer, Diagnostics, Infectious Disease, Therapy, Biopsy, Hormone, Cancer Diagnostic, Medical Robot, Biomarker, Cancer Immunotherapy, Magnetic Resonance Imaging, Oncology, Cancer Biomarker, Ultrasound, DNA, Healthcare, Urology, Urology Device, Biosimilar.


 
1-10 of 85 reports for Prostate Cancer

Purchase Reports From Reputable Market Research Publishers

 Prostate Cancer-API Insights, 2017

Prostate Cancer-API Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuste ...

Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a “Watchful Waiting” and Resistance Population

Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a “Watchful Waiting” and Resistance Population

  • $ 3500
  • Industry report
  • February 2017
  • by MP Advisors

Xtandi – Replacing competitor from Zytiga to Casodex (Bicalutamide) for a bigger pie in Prostate cancer & Finding its niche in crowded BC market Xtandi + Zytiga vs. ARN-509 + Zytiga - Who will win ...

Global Prostate Cancer Partnering 2010 to 2017

Global Prostate Cancer Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • February 2017
  • by Currentpartnering

Summary Provides understanding and access to the prostate cancer partnering deals and agreements entered into by the worlds leading healthcare companies . Description The Global Prostate Cancer Partnering ...

 Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights, 2017

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuste ...

Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides ...

Prostate cancer - Epidemiology Forecast To 2023

Prostate cancer - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Prostate cancer - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Prostate cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). ...

Prostate cancer- Market Insights, Epidemiology and Market Forecast-2023

Prostate cancer- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Prostate cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

 Metastatic Prostate Cancer-API Insights, 2017

Metastatic Prostate Cancer-API Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuste ...

 Metastatic Prostate Cancer-Pipeline Insights, 2017

Metastatic Prostate Cancer-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Metastatic Prostate Cancer-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic Prostate Cancer. ...

About 7200 reports for Prostate Cancer

Download Unlimited Documents from Trusted Public Sources

Prostate Cancer Statistics in Canada

  • November 2015
    128 pages
  • Prostate Cancer  

    Specialty Hospi...  

    Hospital  

  • Canada  

    North America  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.